Syntax Bio

Syntax Bio is a synthetic biology company programming the next generation of cell therapies. Its proprietary Cellgorithm platform uses a CRISPR-based system to program and accelerate stem cell differentiation, replacing slow, labor-intensive processes with a rapid, programmable approach that mimics human development to generate diverse functional cell types at scale. The company is advancing pancreatic beta cell therapy for type 1 diabetes and is backed by DCVC Bio, Astellas Venture Management, Illumina Ventures, and others. Added to the API Evangelist network as a portfolio company of dcvc; enrichment found no public API, developer portal, SDK, or programmatic developer surface as of this pass.

Syntax Bio is profiled on the APIs.io network. Tagged areas include Company, Synthetic Biology, Biotechnology, Cell Therapy, and Life Sciences.

🌐 Visit website 📡 Source on GitHub

5.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanySynthetic BiologyBiotechnologyCell TherapyLife SciencesStem CellsCRISPRRegenerative Medicine

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 5.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/syntax-bio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: syntax-bio
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/syntax-bio.png
name: Syntax Bio
description: Syntax Bio is a synthetic biology company programming the next generation of cell therapies. Its proprietary
  Cellgorithm platform uses a CRISPR-based system to program and accelerate stem cell differentiation, replacing slow, labor-intensive
  processes with a rapid, programmable approach that mimics human development to generate diverse functional cell types at
  scale. The company is advancing pancreatic beta cell therapy for type 1 diabetes and is backed by DCVC Bio, Astellas Venture
  Management, Illumina Ventures, and others. Added to the API Evangelist network as a portfolio company of dcvc; enrichment
  found no public API, developer portal, SDK, or programmatic developer surface as of this pass.
url: https://raw.githubusercontent.com/api-evangelist/syntax-bio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- dcvc
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Synthetic Biology
- Biotechnology
- Cell Therapy
- Life Sciences
- Stem Cells
- CRISPR
- Regenerative Medicine
apis: []
common:
- type: Website
  url: https://www.syntax-bio.com/home
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 0
  pass: local-v1